Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score.
Gragnano F, Jolly SS, Mehta SR, Branca M, van Klaveren D, Frigoli E, Gargiulo G, Leonardi S, Vranckx P, Di Maio D, Monda E, Fimiani L, Fioretti V, Chianese S, Andò G, Esposito G, Sangiorgi GM, Biondi-Zoccai G, Heg D, Calabrò P, Windecker S, Romagnoli E, Valgimigli M. Gragnano F, et al. Among authors: valgimigli m. EuroIntervention. 2021 Dec 17;17(12):e971-e980. doi: 10.4244/EIJ-D-21-00441. EuroIntervention. 2021. PMID: 34374343 Free PMC article. Clinical Trial.
Complete myocardial revascularization: between myth and reality.
Valgimigli M, Agostoni P, Biondi Zoccai GG. Valgimigli M, et al. Eur Heart J. 2005 Sep;26(17):1809-10; author reply 1810-1. doi: 10.1093/eurheartj/ehi403. Epub 2005 Jun 29. Eur Heart J. 2005. PMID: 15987705 No abstract available.
Drawbacks of nonrandomized trials in acute coronary syndromes.
Biondi-Zoccai GG, Abbate A, Agostoni P, Valgimigli M, Sangiorgi GM. Biondi-Zoccai GG, et al. Among authors: valgimigli m. Am J Cardiol. 2006 Jan 1;97(1):151. doi: 10.1016/j.amjcard.2005.07.035. Epub 2005 Sep 15. Am J Cardiol. 2006. PMID: 16377303 No abstract available.
Clinical implications of the PROTECT-TIMI-30 trial.
Valgimigli M, Biondi-Zoccai GG, Agostoni P. Valgimigli M, et al. J Am Coll Cardiol. 2007 Feb 13;49(6):729-30; author reply 730-1. doi: 10.1016/j.jacc.2006.11.012. Epub 2007 Jan 26. J Am Coll Cardiol. 2007. PMID: 17291940 Free article. No abstract available.
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
Lotrionte M, Biondi-Zoccai GG, Agostoni P, Abbate A, Angiolillo DJ, Valgimigli M, Moretti C, Meliga E, Cuisset T, Alessi MC, Montalescot G, Collet JP, Di Sciascio G, Waksman R, Testa L, Sangiorgi G, Laudito A, Trevi GP, Sheiban I. Lotrionte M, et al. Among authors: valgimigli m. Am J Cardiol. 2007 Oct 15;100(8):1199-206. doi: 10.1016/j.amjcard.2007.05.048. Epub 2007 Jul 30. Am J Cardiol. 2007. PMID: 17920357 Review.
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.
Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I. Biondi-Zoccai GG, et al. Among authors: valgimigli m. Am Heart J. 2008 Feb;155(2):274-83. doi: 10.1016/j.ahj.2007.10.009. Epub 2007 Nov 26. Am Heart J. 2008. PMID: 18215597 Review.
Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Marra S, Moretti C, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Meliga E, et al. Among authors: valgimigli m. Int J Cardiol. 2009 Sep 11;137(1):16-21. doi: 10.1016/j.ijcard.2008.06.006. Epub 2008 Aug 6. Int J Cardiol. 2009. PMID: 18687481
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Biondi-Zoccai GG, Valgimigli M, Sheiban I, Margheri M, Marzocchi A, Prati F, Vischi M, Lettieri C, Violini R, Sardella G, Stabile A, Clementi F, Romeo F, Colombo A, Sangiorgi G. Biondi-Zoccai GG, et al. Among authors: valgimigli m. J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):957-62. doi: 10.2459/JCM.0b013e3282ffd3a6. J Cardiovasc Med (Hagerstown). 2008. PMID: 18695440 Clinical Trial.
800 results